NASDAQ:SGNL
Delisted
Signal Genetics Fund Company Profile
$12.30
+0 (+0%)
At Close: Jan 16, 2018
Information
5740 Fleet Street
Carlsbad CA 92008
760-537-4100
Description
Signal Genetics, Inc., a commercial stage molecular genetic diagnostic company, focuses on providing diagnostic services that assist physicians in decision making for the care of patients suffering from cancer. The company primarily offers Myeloma Prognostic Risk Signature (MyPRS) test, a microarray-based gene expression profiling assay that tests for the presence of specific groups of genes that could predict low or high level risk of early relapse in patients suffering from multiple myeloma. Signal Genetics, Inc. was founded in 2010 and is headquartered in Carlsbad, California.